Page last updated: 2024-10-27

gliclazide and Dermatitis, Exfoliative

gliclazide has been researched along with Dermatitis, Exfoliative in 1 studies

Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Dermatitis, Exfoliative: The widespread involvement of the skin by a scaly, erythematous dermatitis occurring either as a secondary or reactive process to an underlying cutaneous disorder (e.g., atopic dermatitis, psoriasis, etc.), or as a primary or idiopathic disease. It is often associated with the loss of hair and nails, hyperkeratosis of the palms and soles, and pruritus. (From Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"Erythroderma is generalized exfoliative dermatitis, which involves more than 90% of the patient's skin."1.40Erythroderma secondary to gliclazide: a case report. ( Kacar, SD; Karaca, S; Ozuguz, P; Ozuguz, U; Tokyol, C, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ozuguz, P1
Kacar, SD1
Ozuguz, U1
Karaca, S1
Tokyol, C1

Other Studies

1 other study available for gliclazide and Dermatitis, Exfoliative

ArticleYear
Erythroderma secondary to gliclazide: a case report.
    Cutaneous and ocular toxicology, 2014, Volume: 33, Issue:4

    Topics: Aged; Dermatitis, Exfoliative; Drug Eruptions; Female; Gliclazide; Humans; Hyperglycemia; Hypoglycem

2014